BCAB
BioAtla, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Jay Short
IPO Date
2020-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
BioAtla, Inc.
CEO
Jay Short
IPO Date
2020-12-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 82 |
| $3.93 |
| 5 Jun 2026 | SHORT JAY M PHD | director, officer: Chief Executive Officer | F-InKind | Disposed | 639 | $0.17 |
| 5 Jun 2026 | SHORT JAY M PHD | director, officer: Chief Executive Officer | F-InKind | Disposed | 259 | $3.93 |
| 5 Jun 2026 | Sievers Eric | Chief Medical Officer | F-InKind | Disposed | 360 | $0.17 |
| 5 Jun 2026 | Sievers Eric | Chief Medical Officer | F-InKind | Disposed | 134 | $3.93 |
| 12 Mar 2026 | Sievers Eric | Chief Medical Officer | A-Award | Acquired | 240,000 | $0.00 |
| 12 Mar 2026 | SHORT JAY M PHD | director, officer: Chief Executive Officer | A-Award | Acquired | 430,000 | $0.00 |
| 12 Mar 2026 | Vasquez Christian | Chief Financial Officer | A-Award | Acquired | 240,000 | $0.00 |
| 2 Mar 2026 | SHORT JAY M PHD | director, officer: Chief Executive Officer | F-InKind | Disposed | 7,728 | $0.25 |